VRTX
Vertex Pharmaceuticals Inc
526.20$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.53 | 9.65 | 10.29 | 10.25 | 10.62 | 11.18 | 10.68 | 11.45 | 11.94 | 12.60 | 11.65 | 13.04 | 49.37 | |
| 1.22 | 1.41 | 1.31 | 1.44 | 1.50 | 1.63 | 1.40 | 1.57 | 1.61 | 1.82 | 1.53 | 1.91 | 6.89 | |
| 8.31 | 8.24 | 8.98 | 8.81 | 9.12 | 9.55 | 9.28 | 9.88 | 10.33 | 10.78 | 10.12 | 11.13 | 42.48 | |
| 3.31 | 5.18 | 3.32 | 20.98 | 3.36 | 3.83 | 3.78 | 3.78 | 4.01 | 3.80 | 3.75 | 3.89 | 15.49 | |
| 1.01 | 1.41 | 1.31 | 1.44 | 1.42 | 1.45 | 1.53 | 1.64 | 1.73 | 1.90 | 1.93 | 2.28 | 7.85 | |
| 4.32 | 4.45 | 4.63 | 22.43 | 4.84 | 5.61 | 6.85 | 5.43 | 5.73 | 5.70 | 5.68 | 6.25 | 23.43 | |
| 3.98 | 3.79 | 4.36 | -13.62 | 4.28 | 3.94 | 2.43 | 4.45 | 4.60 | 5.08 | 4.44 | 4.88 | 19.05 | |
| 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | – | – | – | |
| 4.52 | 4.40 | 4.90 | -13.14 | 4.69 | 4.36 | 2.81 | 4.96 | 5.04 | 5.20 | 4.89 | 5.44 | 20.63 | |
| 0.55 | 0.69 | 0.69 | 0.78 | 0.68 | 0.86 | 0.32 | 0.97 | 0.84 | 0.55 | 0.86 | 1.14 | 3.40 | |
| 3.97 | 3.71 | 4.21 | -13.92 | 4.01 | 3.50 | 2.49 | 3.99 | 4.20 | 4.65 | 4.02 | 4.30 | 17.23 | |
| 4.73 | 4.67 | 5.14 | -12.89 | 4.92 | 4.55 | 3.01 | 5.17 | 5.26 | 5.42 | 5.11 | 5.44 | 21.29 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.